oncology

Rather than grimly assembling data about cancer deaths to predict outcomes in treatment, the founders of Cure51 had another idea.

Cure51 raises a €15M seed round aiming to crack the code on cancer survival

This week, we are taking a closer look at Pepper Bio’s seed pitch deck that landed the company $6.5 million.

Pitch Deck Teardown: Pepper Bio’s $6.5M seed deck

An innovative new medical startup in Romania helped doctors from three countries collaborate to treat Ukrainian cancer patients made refugees after Russia’s brutal invasion. The “Tumor Board” project was initiated…

How a Romanian medtech startup helped US doctors treat refugee Ukrainian cancer patients

What goes on in that gastrointestinal tract of yours? Well, we have a general idea, but evidence is mounting that the gut and the microbes that live there play an…

Persephone puts poop to work to explore and heal your gut microbiome

In the creation of a new drug, there comes a point where you have to finally put the molecule in a real creature — one at a time — and…

Manifold Bio’s molecular ‘barcodes’ could break through pharma’s in vivo bottleneck

A hot bowl of pad thai simmers in front of you. The taste and texture is exactly what you might expect from a quick takeout dinner, but it’s not just…

Faeth Therapeutics closes $20M seed to turn nutrition into a pillar of cancer treatment

Hummingbird Bioscience, a startup focused on developing new treatments for cancer and other diseases, announced today it has added $6 million to its previously announced Series B, bringing the round’s…

Biotherapeutics startup Hummingbird Bioscience brings its total Series B funding to $25 million

Trialjectory, which is developing a new technology service to match cancer patients with clinical trials, has raised $2.7 million to finance its continued growth. Led by Contour Venture Partners, the…

Trialjectory uses self-reported clinical data to match cancer patients with clinical trials

For more than 25 years the founders of Thrive Earlier Detection have been researching ways to improve the accuracy of liquid biopsy tests. The fruits of that labor from Dr.…

Pitching accuracy rates of over 99% for multiple cancer screens, Thrive launches with $110 million

Investors and entrepreneurs are beginning to bring new diagnostic tools to market that promise better results for cancer patients through the identification of mutations in cancer cells that can create…

Companies tracking mutations in cancer cells can provide a key to unlocking better therapies

Scientists in collaboration with tech billionaire Sean Parker’s Institute for Cancer Immunotherapy may have found a way to predict whether melanoma patients will respond to treatments that target the PD-1…

Sean Parker’s cancer institute may have found a blood test to see if patients will respond to treatment

A New York City startup called The Mednet today launched a platform that gives physicians a knowledge-sharing tool that’s as easy to use as Quora, but provides them with expert…

The Mednet launches its ‘Quora for cancer,’ an online medical knowledge base